Atlas Trials

Study of AggreGuide A-100 (ADP) Assay

Clinical trial NCT03111420 · COMPLETED

Trial details

NCT number
NCT03111420
Sponsor
Aggredyne, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Risk Factor, CardiovascularPlatelet Dysfunction Due to Drugs
Start date
2017-01-09
Primary completion
2018-06-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.